Skip to main content
logo
Myriad Genetics, Inc. (LON:0K3W)
London flag London · Delayed Price · Currency is GBP · Price in USD
6.35
-0.32 (-4.78%)
At close: Nov 6, 2025

Myriad Genetics Revenue

Myriad Genetics had revenue of $205.70M USD in the quarter ending September 30, 2025, a decrease of -3.56%. This brings the company's revenue in the last twelve months to $825.30M, up 0.21% year-over-year. In the year 2024, Myriad Genetics had annual revenue of $837.60M with 11.21% growth.

Revenue (ttm)
$825.30M
Revenue Growth
+0.21%
P/S Ratio
0.73
Revenue / Employee
$305.67K
Employees
2,700
Market Cap
450.23M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024837.60M84.40M11.21%
Dec 31, 2023753.20M74.80M11.03%
Dec 31, 2022678.40M-12.20M-1.77%
Dec 31, 2021690.60M133.60M23.99%
Dec 31, 2020557.00M-81.60M-12.78%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca41.24B
GSK plc32.17B
Haleon11.02B
Smith & Nephew4.33B
Hikma Pharmaceuticals2.35B
ConvaTec Group1.72B
Spire Healthcare Group1.55B
Genus672.80M
Revenue Rankings

Myriad Genetics News

More News